New approaches to treatment of ischemic heart disease: Therapeutic angiogenesis in combination with surgical revascularization of the myocardium

Terapevticheskii Arkhiv

Volumn 76, Issue 6, 2004, Pages 25-30

  Bockeria, L A ^a   Golukhova, E Z ^a   Eremeeva, M V ^a   Kiselev, S L ^a   Aslanidi, I P ^a   Vakhromeeva, M N ^a   Klyueva, A F ^a   Polyakova, E S ^a   Lukashkin, M A ^a  

^a NONE

Author keywords

Ischemic heart disease; Surgical revascularization; Therapeutic angiogenesis

Indexed keywords

NITRIC ACID; TECHNETIUM 99M; VASCULOTROPIN; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; ORGANOPHOSPHORUS COMPOUND; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, HUMAN; VASCULOTROPIN A;

ANALYTIC METHOD; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORONARY ARTERY BYPASS GRAFT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EXERCISE TOLERANCE; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HUMAN; ISCHEMIC HEART DISEASE; QUALITY OF LIFE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS; SURGICAL TECHNIQUE; TRANSTHORACIC ECHOCARDIOGRAPHY; TREADMILL EXERCISE; ANGIOCARDIOGRAPHY; CLINICAL TRIAL; COLLATERAL CIRCULATION; DRUG EFFECT; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART MUSCLE ISCHEMIA; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; TREATMENT OUTCOME;

COLLATERAL CIRCULATION; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; QUALITY OF LIFE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 3042611770     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Freedman S. B. Therapeutic angiogenesis for coronary artery disease. Ann. Intern. Med. 2002; 136 (1): 54-71.
2. Hamaway A. H., Lee L. Y., Crystal R. G. et al. Cardiac angiogenesis and gene therapy: A strategy for myocardial revascularization. Curr. Opin. Cardiol. 1999; 14: 515-522.
3. Hudlicka O., Brown M. D., Walter H. et al. Factors involved in capillary growth in the heart. Mol. Cell. Biochem. 1995; 147 (1-2): 57-68.
4. Harada K. et al. Vascular endothelial growth factor in chronic myocardial ischemia. Am. J. Physiol. 1996; 270: H1791-H1802.
5. Post M., Ware J. A. Angiogenesis in atherosclerosis and restenosis. In: Angiogenesis and cardiovascular disease. New York, Oxford: Oxford University Press; 1999.
6. Losordo D. W., Vale P. R., Symes J. F. et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischaemia. Circulation 1998; 98: 2800-2804.
7. Levin D. C., Beckmann C. F., Sos T. A., Sniderman K. Incomplete myocardial reperfusion despite a patent coronary bypass: a generally unrecognized shortcoming of the surgical approach to coronary artery disease. Radiology 1982; 142: 317-321.
8. Grines C. L., Watkins M. W., Helmer G. et al. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation 2002; 105 (11): 1291-1297.
9. Hedman M., Hartikainen J., Syvanne M. et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 2003; 107 (21): 2677-2683.